BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17088433)

  • 21. NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.
    Sharma AK; LaPar DJ; Stone ML; Zhao Y; Mehta CK; Kron IL; Laubach VE
    Am J Respir Crit Care Med; 2016 May; 193(9):988-99. PubMed ID: 26757359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
    Ilyinskii PO; Wang R; Balk SP; Exley MA
    J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein.
    Shimamura K; Kawamura H; Nagura T; Kato T; Naito T; Kameyama H; Hatakeyama K; Abo T
    Cell Immunol; 2005 Mar; 234(1):31-8. PubMed ID: 15963482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
    Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
    J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.
    Day YJ; Huang L; McDuffie MJ; Rosin DL; Ye H; Chen JF; Schwarzschild MA; Fink JS; Linden J; Okusa MD
    J Clin Invest; 2003 Sep; 112(6):883-91. PubMed ID: 12975473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury.
    Zhang J; Han C; Dai H; Hou J; Dong Y; Cui X; Xu L; Zhang M; Xia Q
    J Am Soc Nephrol; 2016 Jan; 27(1):92-106. PubMed ID: 25956511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis.
    Ohnishi Y; Tsutsumi A; Goto D; Itoh S; Matsumoto I; Taniguchi M; Sumida T
    Clin Exp Immunol; 2005 Jul; 141(1):47-53. PubMed ID: 15958069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
    Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
    J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
    Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
    J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
    Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
    J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells.
    Ishikawa H; Tanaka K; Kutsukake E; Fukui T; Sasaki H; Hata A; Noda S; Matsumoto T
    Virology; 2010 Nov; 407(2):325-32. PubMed ID: 20855097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.
    Ranson T; Bregenholt S; Lehuen A; Gaillot O; Leite-de-Moraes MC; Herbelin A; Berche P; Di Santo JP
    J Immunol; 2005 Jul; 175(2):1137-44. PubMed ID: 16002715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
    Durante-Mangoni E; Wang R; Shaulov A; He Q; Nasser I; Afdhal N; Koziel MJ; Exley MA
    J Immunol; 2004 Aug; 173(3):2159-66. PubMed ID: 15265953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD1d-independent regulation of NKT cell migration and cytokine production upon Listeria monocytogenes infection.
    Arrunategui-Correa V; Lenz L; Kim HS
    Cell Immunol; 2004; 232(1-2):38-48. PubMed ID: 15922714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells.
    Sonoda KH; Taniguchi M; Stein-Streilein J
    J Immunol; 2002 Feb; 168(4):2028-34. PubMed ID: 11823540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.